GlassScriptPhysician profile
Brian D Belnap
NPI 1457360448
$819.60
in general payments reported to CMS, 2019-2025
18 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $109 · 2021: $153 · 2022: $76.76 · 2023: $118 · 2024: $80.26 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $186.65 | 2019-2023 | Hymovis |
| Abbott Laboratories | $154.40 | 2020-2025 | Prodigy, Proclaim |
| Boston Scientific Corporation | $75.39 | 2025 | Wavewriter Alpha Prime 16 |
| Pacira Therapeutics, INC. | $44.84 | 2019-2021 | |
| Pfizer INC. | $40.93 | 2019 | |
| Collegium Pharmaceutical, INC. | $37.80 | 2021-2022 | |
| Nalu Medical, INC. | $35.79 | 2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $31.94 | 2025 | Sprint Pns System |
| Sanofi-Aventis U.S. LLC | $29.17 | 2019-2020 | |
| Depuy Synthes Sales INC. | $28.99 | 2021-2023 | Orthovisc |
| Forte Bio-Pharma LLC | $27.13 | 2024 | Prolate, Nalocet |
| Nevro Corp. | $23.07 | 2023 | Senza |
| Scilex Pharmaceuticals INC. | $22.78 | 2019 | |
| Avanos Medical | $21.01 | 2023 | Trivisc Sodium Hyaluronate |
| Elevate Surgical Co | $17.34 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $17.15 | 2023 | |
| Si-Bone, INC. | $13.57 | 2019 | |
| Biodelivery Sciences International, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Belnap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.